Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Transepithelial CXL for Keratoconus
NCT02456961Completed
- Sponsor
- Ufa Eye Research Institute
- Start
- Jan 2010
- Primary completion
- Dec 2014
01
Overview
Randomised, open-label trial (2 arms), sponsored by Ufa Eye Research Institute. Primary endpoint: Maximum Keratometry at 2 years. Started Jan 2010; status: completed.
Beyond the preview
Go deeper on NCT02456961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456961.